Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: Results from the DIVA study group

V. Svicher; C. Alteri; M. Montano; A. Nori; R. D'Arrigo; M. Andreoni; G. Angarano; A. Antinori; G. Antonelli; T. Allice; P. Bagnarelli; F. Baldanti; A. Bertoli; M. Borderi; E. Boeri; I. Bon; B. Bruzzone; R. Barresi; S. Calderisi; A. P. Callegaro; M. R. Capobianchi; F. Gargiulo; F. Castelli; R. Cauda; F. Ceccherini-Silberstein; M. Clementi; A. Chirianni; M. Colafigli; A. D'Arminio Monforte; A. De Luca; A. Di Biagio; G. Di Nicuolo; G. Di Perri; F. Di Santo; G. Fadda; M. Galli; W. Gennari; V. Ghisetti; A. Costantini; A. Gori; R. Gulminetti; F. Leoncini; G. Maffongelli; F. Maggiolo; R. Maserati; F. Mazzotta; G. Meini; V. Micheli; L. Monno; C. Mussini; S. Nozza; S. Paolucci; G. Palù; S. Parisi; G. Parruti; A. R. Pignataro; T. Quirino; M. C. Re; G. Rizzardini; M. Sanguinetti; R. Santangelo; R. Scaggiante; G. Sterrantino; O. Turriziani; M. L. Vatteroni; C. Viscoli; V. Vullo; M. Zazzi; A. Lazzarin; C. F. Perno

doi:10.1007/s15010-013-0510-3

Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: Results from the DIVA study group

V. Svicher, C. Alteri, M. Montano, A. Nori, R. D'Arrigo, M. Andreoni, G. Angarano, A. Antinori, G. Antonelli, T. Allice, P. Bagnarelli, F. Baldanti, A. Bertoli, M. Borderi, E. Boeri, I. Bon, B. Bruzzone, R. Barresi, S. Calderisi, A. P. CallegaroM. R. Capobianchi, F. Gargiulo, F. Castelli, R. Cauda, F. Ceccherini-Silberstein, M. Clementi, A. Chirianni, M. Colafigli, A. D'Arminio Monforte, A. De Luca, A. Di Biagio, G. Di Nicuolo, G. Di Perri, F. Di Santo, G. Fadda, M. Galli, W. Gennari, V. Ghisetti, A. Costantini, A. Gori, R. Gulminetti, F. Leoncini, G. Maffongelli, F. Maggiolo, R. Maserati, F. Mazzotta, G. Meini, V. Micheli, L. Monno, C. Mussini, S. Nozza, S. Paolucci, G. Palù, S. Parisi, G. Parruti, A. R. Pignataro, T. Quirino, M. C. Re, G. Rizzardini, M. Sanguinetti, R. Santangelo, R. Scaggiante, G. Sterrantino, O. Turriziani, M. L. Vatteroni, C. Viscoli, V. Vullo, M. Zazzi, A. Lazzarin, C. F. Perno

Research output: Contribution to journal › Article › peer-review

Abstract

Purpose: We have developed a sequencing assay for determining the usage of the genotypic HIV-1 co-receptor using peripheral blood mononuclear cell (PBMC) DNA in virologically suppressed HIV-1 infected patients. Our specific aims were to (1) evaluate the efficiency of V3 sequences in B versus non-B subtypes, (2) compare the efficiency of V3 sequences and tropism prediction using whole blood and PBMCs for DNA extraction, (3) compare the efficiency of V3 sequences and tropism prediction using a single versus a triplicate round of amplification. Results: The overall rate of successful V3 sequences ranged from 100% in samples with >3,000 copies HIV-1 DNA/106 PBMCs to 60% in samples with

Original language	English
Pages (from-to)	61-71
Number of pages	11
Journal	Infection
Volume	42
Issue number	1
DOIs	https://doi.org/10.1007/s15010-013-0510-3
Publication status	Published - 2014

Keywords

CCR5 antagonists
Geno2pheno
HIV DNA
Tropism
Virologically suppressed patients

ASJC Scopus subject areas

Microbiology (medical)
Infectious Diseases

Access to Document

10.1007/s15010-013-0510-3

Fingerprint Dive into the research topics of 'Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: Results from the DIVA study group'. Together they form a unique fingerprint.

Cite this

Svicher, V., Alteri, C., Montano, M., Nori, A., D'Arrigo, R., Andreoni, M., Angarano, G., Antinori, A., Antonelli, G., Allice, T., Bagnarelli, P., Baldanti, F., Bertoli, A., Borderi, M., Boeri, E., Bon, I., Bruzzone, B., Barresi, R., Calderisi, S., ... Perno, C. F. (2014). Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: Results from the DIVA study group. Infection, 42(1), 61-71. https://doi.org/10.1007/s15010-013-0510-3

Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice : Results from the DIVA study group. / Svicher, V.; Alteri, C.; Montano, M.; Nori, A.; D'Arrigo, R.; Andreoni, M.; Angarano, G.; Antinori, A.; Antonelli, G.; Allice, T.; Bagnarelli, P.; Baldanti, F.; Bertoli, A.; Borderi, M.; Boeri, E.; Bon, I.; Bruzzone, B.; Barresi, R.; Calderisi, S.; Callegaro, A. P.; Capobianchi, M. R.; Gargiulo, F.; Castelli, F.; Cauda, R.; Ceccherini-Silberstein, F.; Clementi, M.; Chirianni, A.; Colafigli, M.; D'Arminio Monforte, A.; De Luca, A.; Di Biagio, A.; Di Nicuolo, G.; Di Perri, G.; Di Santo, F.; Fadda, G.; Galli, M.; Gennari, W.; Ghisetti, V.; Costantini, A.; Gori, A.; Gulminetti, R.; Leoncini, F.; Maffongelli, G.; Maggiolo, F.; Maserati, R.; Mazzotta, F.; Meini, G.; Micheli, V.; Monno, L.; Mussini, C.; Nozza, S.; Paolucci, S.; Palù, G.; Parisi, S.; Parruti, G.; Pignataro, A. R.; Quirino, T.; Re, M. C.; Rizzardini, G.; Sanguinetti, M.; Santangelo, R.; Scaggiante, R.; Sterrantino, G.; Turriziani, O.; Vatteroni, M. L.; Viscoli, C.; Vullo, V.; Zazzi, M.; Lazzarin, A.; Perno, C. F.

In: Infection, Vol. 42, No. 1, 2014, p. 61-71.

Research output: Contribution to journal › Article › peer-review

Svicher, V, Alteri, C, Montano, M, Nori, A, D'Arrigo, R, Andreoni, M, Angarano, G, Antinori, A, Antonelli, G, Allice, T, Bagnarelli, P, Baldanti, F, Bertoli, A, Borderi, M, Boeri, E, Bon, I, Bruzzone, B, Barresi, R, Calderisi, S, Callegaro, AP, Capobianchi, MR, Gargiulo, F, Castelli, F, Cauda, R, Ceccherini-Silberstein, F, Clementi, M, Chirianni, A, Colafigli, M, D'Arminio Monforte, A, De Luca, A, Di Biagio, A, Di Nicuolo, G, Di Perri, G, Di Santo, F, Fadda, G, Galli, M, Gennari, W, Ghisetti, V, Costantini, A, Gori, A, Gulminetti, R, Leoncini, F, Maffongelli, G, Maggiolo, F, Maserati, R, Mazzotta, F, Meini, G, Micheli, V, Monno, L, Mussini, C, Nozza, S , Paolucci, S, Palù, G, Parisi, S, Parruti, G, Pignataro, AR, Quirino, T, Re, MC, Rizzardini, G, Sanguinetti, M, Santangelo, R, Scaggiante, R, Sterrantino, G, Turriziani, O, Vatteroni, ML, Viscoli, C, Vullo, V, Zazzi, M, Lazzarin, A & Perno, CF 2014, 'Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: Results from the DIVA study group', Infection, vol. 42, no. 1, pp. 61-71. https://doi.org/10.1007/s15010-013-0510-3

Svicher, V. ; Alteri, C. ; Montano, M. ; Nori, A. ; D'Arrigo, R. ; Andreoni, M. ; Angarano, G. ; Antinori, A. ; Antonelli, G. ; Allice, T. ; Bagnarelli, P. ; Baldanti, F. ; Bertoli, A. ; Borderi, M. ; Boeri, E. ; Bon, I. ; Bruzzone, B. ; Barresi, R. ; Calderisi, S. ; Callegaro, A. P. ; Capobianchi, M. R. ; Gargiulo, F. ; Castelli, F. ; Cauda, R. ; Ceccherini-Silberstein, F. ; Clementi, M. ; Chirianni, A. ; Colafigli, M. ; D'Arminio Monforte, A. ; De Luca, A. ; Di Biagio, A. ; Di Nicuolo, G. ; Di Perri, G. ; Di Santo, F. ; Fadda, G. ; Galli, M. ; Gennari, W. ; Ghisetti, V. ; Costantini, A. ; Gori, A. ; Gulminetti, R. ; Leoncini, F. ; Maffongelli, G. ; Maggiolo, F. ; Maserati, R. ; Mazzotta, F. ; Meini, G. ; Micheli, V. ; Monno, L. ; Mussini, C. ; Nozza, S. ; Paolucci, S. ; Palù, G. ; Parisi, S. ; Parruti, G. ; Pignataro, A. R. ; Quirino, T. ; Re, M. C. ; Rizzardini, G. ; Sanguinetti, M. ; Santangelo, R. ; Scaggiante, R. ; Sterrantino, G. ; Turriziani, O. ; Vatteroni, M. L. ; Viscoli, C. ; Vullo, V. ; Zazzi, M. ; Lazzarin, A. ; Perno, C. F. / Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice : Results from the DIVA study group. In: Infection. 2014 ; Vol. 42, No. 1. pp. 61-71.

@article{356af3b50e7d40fd912e5ff31da2f37b,

title = "Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: Results from the DIVA study group",

abstract = "Purpose: We have developed a sequencing assay for determining the usage of the genotypic HIV-1 co-receptor using peripheral blood mononuclear cell (PBMC) DNA in virologically suppressed HIV-1 infected patients. Our specific aims were to (1) evaluate the efficiency of V3 sequences in B versus non-B subtypes, (2) compare the efficiency of V3 sequences and tropism prediction using whole blood and PBMCs for DNA extraction, (3) compare the efficiency of V3 sequences and tropism prediction using a single versus a triplicate round of amplification. Results: The overall rate of successful V3 sequences ranged from 100% in samples with >3,000 copies HIV-1 DNA/106 PBMCs to 60% in samples with ",

keywords = "CCR5 antagonists, Geno2pheno, HIV DNA, Tropism, Virologically suppressed patients",

author = "V. Svicher and C. Alteri and M. Montano and A. Nori and R. D'Arrigo and M. Andreoni and G. Angarano and A. Antinori and G. Antonelli and T. Allice and P. Bagnarelli and F. Baldanti and A. Bertoli and M. Borderi and E. Boeri and I. Bon and B. Bruzzone and R. Barresi and S. Calderisi and Callegaro, {A. P.} and Capobianchi, {M. R.} and F. Gargiulo and F. Castelli and R. Cauda and F. Ceccherini-Silberstein and M. Clementi and A. Chirianni and M. Colafigli and {D'Arminio Monforte}, A. and {De Luca}, A. and {Di Biagio}, A. and {Di Nicuolo}, G. and {Di Perri}, G. and {Di Santo}, F. and G. Fadda and M. Galli and W. Gennari and V. Ghisetti and A. Costantini and A. Gori and R. Gulminetti and F. Leoncini and G. Maffongelli and F. Maggiolo and R. Maserati and F. Mazzotta and G. Meini and V. Micheli and L. Monno and C. Mussini and S. Nozza and S. Paolucci and G. Pal{\`u} and S. Parisi and G. Parruti and Pignataro, {A. R.} and T. Quirino and Re, {M. C.} and G. Rizzardini and M. Sanguinetti and R. Santangelo and R. Scaggiante and G. Sterrantino and O. Turriziani and Vatteroni, {M. L.} and C. Viscoli and V. Vullo and M. Zazzi and A. Lazzarin and Perno, {C. F.}",

year = "2014",

doi = "10.1007/s15010-013-0510-3",

language = "English",

volume = "42",

pages = "61--71",

journal = "Infection",

issn = "0300-8126",

publisher = "Urban und Vogel GmbH",

number = "1",

}

TY - JOUR

T1 - Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice

T2 - Results from the DIVA study group

AU - Svicher, V.

AU - Alteri, C.

AU - Montano, M.

AU - Nori, A.

AU - D'Arrigo, R.

AU - Andreoni, M.

AU - Angarano, G.

AU - Antinori, A.

AU - Antonelli, G.

AU - Allice, T.

AU - Bagnarelli, P.

AU - Baldanti, F.

AU - Bertoli, A.

AU - Borderi, M.

AU - Boeri, E.

AU - Bon, I.

AU - Bruzzone, B.

AU - Barresi, R.

AU - Calderisi, S.

AU - Callegaro, A. P.

AU - Capobianchi, M. R.

AU - Gargiulo, F.

AU - Castelli, F.

AU - Cauda, R.

AU - Ceccherini-Silberstein, F.

AU - Clementi, M.

AU - Chirianni, A.

AU - Colafigli, M.

AU - D'Arminio Monforte, A.

AU - De Luca, A.

AU - Di Biagio, A.

AU - Di Nicuolo, G.

AU - Di Perri, G.

AU - Di Santo, F.

AU - Fadda, G.

AU - Galli, M.

AU - Gennari, W.

AU - Ghisetti, V.

AU - Costantini, A.

AU - Gori, A.

AU - Gulminetti, R.

AU - Leoncini, F.

AU - Maffongelli, G.

AU - Maggiolo, F.

AU - Maserati, R.

AU - Mazzotta, F.

AU - Meini, G.

AU - Micheli, V.

AU - Monno, L.

AU - Mussini, C.

AU - Nozza, S.

AU - Paolucci, S.

AU - Palù, G.

AU - Parisi, S.

AU - Parruti, G.

AU - Pignataro, A. R.

AU - Quirino, T.

AU - Re, M. C.

AU - Rizzardini, G.

AU - Sanguinetti, M.

AU - Santangelo, R.

AU - Scaggiante, R.

AU - Sterrantino, G.

AU - Turriziani, O.

AU - Vatteroni, M. L.

AU - Viscoli, C.

AU - Vullo, V.

AU - Zazzi, M.

AU - Lazzarin, A.

AU - Perno, C. F.

PY - 2014

Y1 - 2014

N2 - Purpose: We have developed a sequencing assay for determining the usage of the genotypic HIV-1 co-receptor using peripheral blood mononuclear cell (PBMC) DNA in virologically suppressed HIV-1 infected patients. Our specific aims were to (1) evaluate the efficiency of V3 sequences in B versus non-B subtypes, (2) compare the efficiency of V3 sequences and tropism prediction using whole blood and PBMCs for DNA extraction, (3) compare the efficiency of V3 sequences and tropism prediction using a single versus a triplicate round of amplification. Results: The overall rate of successful V3 sequences ranged from 100% in samples with >3,000 copies HIV-1 DNA/106 PBMCs to 60% in samples with

AB - Purpose: We have developed a sequencing assay for determining the usage of the genotypic HIV-1 co-receptor using peripheral blood mononuclear cell (PBMC) DNA in virologically suppressed HIV-1 infected patients. Our specific aims were to (1) evaluate the efficiency of V3 sequences in B versus non-B subtypes, (2) compare the efficiency of V3 sequences and tropism prediction using whole blood and PBMCs for DNA extraction, (3) compare the efficiency of V3 sequences and tropism prediction using a single versus a triplicate round of amplification. Results: The overall rate of successful V3 sequences ranged from 100% in samples with >3,000 copies HIV-1 DNA/106 PBMCs to 60% in samples with

KW - CCR5 antagonists

KW - Geno2pheno

KW - HIV DNA

KW - Tropism

KW - Virologically suppressed patients

UR - http://www.scopus.com/inward/record.url?scp=84898546832&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84898546832&partnerID=8YFLogxK

U2 - 10.1007/s15010-013-0510-3

DO - 10.1007/s15010-013-0510-3

M3 - Article

C2 - 24146352

AN - SCOPUS:84898546832

VL - 42

SP - 61

EP - 71

JO - Infection

JF - Infection

SN - 0300-8126

IS - 1

ER -

Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: Results from the DIVA study group

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this